Skip to main content
. 2018 Mar 1;9(3):344. doi: 10.1038/s41419-018-0364-9

Fig. 3.

Fig. 3

Kaplan–Meier models of survival and metastasis development for MTSS1 (a, b), SCAMP1 (c, d) and SERPIN B13 (e, f) loss, respectively. Less favourable prognosis is seen in patients with ‘pure’ HER2+ tumours compared to other patients showing loss of these biomarkers. Scale bar = 100 μm